<DOC>
	<DOC>NCT01953172</DOC>
	<brief_summary>The study is designed to investigate the effect of AMP886 (alpha-tocotrienol) on health status and quality of life measures, cognitive functioning, oxidative stress, inflammation markers and other symptoms effects on skin, sleep and vision in the elderly.</brief_summary>
	<brief_title>Health Status and Quality of Life in the Elderly</brief_title>
	<detailed_description />
	<mesh_term>Tocotrienol, alpha</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<criteria>Males and females 6585 years old ECOG Performance score 0 to 1 Body mass index 2230 kg/m2 Body weight &gt;60 kg Habit to consume standard breakfast like toast, bread, butter/margarine, eggs, bacon, cereals with milk Comply with protocol and likely to be compliant with prescribed product Renal insufficiency or failure at screening Current or previous positive documented history of any chronic inflammatory state including chronic infection, arthritis, or collagen vascular disorder. Comorbid medical conditions Use of prescription medication for chronic conditions Use of hormone replacement therapy (with the exception of levothyroxine) Uncontrolled hypertension Use of hemostatic agents Hemorrhagic disorder and/or coagulation disorder Clinically important bleeding within 90 days prior to screening visit Fat malabsorption syndromes Constipation and/or abdominal pain/discomfort that require dietary supplements or medical therapy History of smoking within 1 year prior to visit 1.</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>